Targeting newly identified ERβ/TGF‐β1/SMAD3 signals with the FDA‐approved anti‐estrogen Faslodex or an ERβ selective antagonist in renal cell carcinoma

Author:

Song Wenbin12,He Dalin1,Chen Yule1,Yeh Chiuan‐Ren2,Hsu Iawen2,Huang Qingbo3,Zhang Xu3,Chang Luke Sien‐Shih1,Zuo Li2,Chen Jiasheng2,Doersch Karen M.2,Chang Chawnshang2,Li Lei1,Yeh Shuyuan2

Affiliation:

1. Department of Urology The First Affiliated Hospital Xi'an Jiaotong University China

2. George Whipple Lab for Cancer Research Departments of Urology and Pathology University of Rochester Medical Center NY USA

3. Department of Urology Chinese PLA General Hospital Beijing China

Funder

National Natural Science Foundation of China

Publisher

Wiley

Subject

Cancer Research,Genetics,Molecular Medicine,General Medicine,Oncology

Reference43 articles.

1. Study of tamoxifen in metastatic renal cell carcinoma and the influence of certain prognostic factors: a Southwest Oncology Group Study;Al‐Sarraf M;Cancer Treat Rep,1980

2. Risk factors in renal cell carcinoma: I. Methodology, demographics, tobacco, beverage use, and obesity;Asal NR;Cancer Detect Prev,1988

3. A dynamic in vivo model of epithelial-to-mesenchymal transitions in circulating tumor cells and metastases of breast cancer

4. Expression of estrogen receptor (ER) subtypes and ERbeta isoforms in colon cancer;Campbell‐Thompson M;Cancer Res,2001

5. Estrogen and prostate cancer: An eclipsed truth in an androgen-dominated scenario

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3